Basket cover image
15 handpicked stocks

Sin Stocks

This carefully selected group of stocks represents leading companies in alcohol, tobacco, and gaming industries. These companies tend to perform steadily regardless of economic conditions, making them valuable additions to your portfolio during uncertain times.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at जून 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

MO

Altria Group Inc.

MO

Current price

$66.56

As a leading U.S. producer of iconic cigarette and oral tobacco brands, it is a cornerstone of the traditional tobacco industry.

PM

Philip Morris International, Inc.

PM

Current price

$168.77

This company is a global leader in the tobacco market, selling well-known cigarette brands and investing in smoke-free alternatives worldwide.

BTI

British American Tobacco p.l.c.

BTI

Current price

$57.47

It represents a major global player in the tobacco sector with a diverse portfolio of combustible and next-generation nicotine products.

About This Group of Stocks

1

Our Expert Thinking

These "sin stocks" represent companies with non-cyclical consumer demand in alcohol, tobacco, and gaming. They typically maintain steady sales even during economic downturns, as customers continue to purchase these products regardless of broader market conditions.

2

What You Need to Know

Companies in this group often generate strong, consistent cash flows and many pay reliable dividends. The portfolio includes established global brands with dominant market positions across various vice industries, offering potential stability during market volatility.

3

Why These Stocks

Each company was selected for its leadership position and strong performance within its respective industry. Current growth catalysts include expanding legalization of sports betting and online gaming, creating new revenue opportunities for many companies in this group.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+44.22%

Group Performance Snapshot

44.22%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 44.22% over the next year.

12 of 15

Stocks Rated Buy by Analysts

12 of 15 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🛡️

Recession-Resistant Returns

Sin stocks typically maintain sales during economic downturns, as consumers continue to purchase these products regardless of their financial situation, providing portfolio protection when other sectors struggle.

💰

Steady Dividend Income

Many companies in this group generate strong, reliable cash flows and have histories of consistent dividend payments, making them attractive options for income-focused investors.

🚀

Sports Betting Boom

The rapid legalization of sports betting and online gaming across the U.S. and globally is creating massive new market opportunities for several companies in this collection.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.